SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

JIMENEZ MALAGON, M.C. et al. Manifestaciones orales en pacientes VIH/SIDA asociadas a tratamiento antirretroviral y el estado inmunológico en dos fundaciones de la ciudad de Cartagena. Av Odontoestomatol [online]. 2012, vol.28, n.4, pp.181-189. ISSN 0213-1285.

    1. Pinzón E, Bravo S, Méndez F, Clavijo G, León M. Prevalence and factors related with the presence of oral manifestations in HIV/AIDS patients who attended health institutions in Cali, Colombia. Colomb Med 2008 Oct;39(4):346-55. [ Links ]

    2. UNAIDS/WHO. Situación de la epidemia de sida 2009. www.onusida.org.co. [ Links ]

    3. Infección por VIH/SIDA en Colombia. Estado del arte 2005. Situación epidemiológica. www.onusida.org.co. [ Links ]

    4. Gileva OS, Sazhina MV, Gileva ES, Efimov AV, Scully C. Spectrum of oral manifestationsof HIV/AIDS in the Perm region (Russia) and identification of self-induced ulceronecrotic lingual lesions. Med Oral 2004 May;9(3):212-5. [ Links ]

    5. Patton LL, Phelan JA, Ramos-Gomez FJ, Nittayananta W, Shiboski CH, Mbuguye TL. Prevalence and classification of HIV-associated oral lesions. Oral Dis 2002;8 Suppl 2:98-109. [ Links ]

    6. Estrada J. Oral lesions associated to HIV infection and AIDS in individuals without antiretroviral treatment in Bogotá, DC. Biomédica 2001 Dec; 21(4):333-44. [ Links ]

    7. Coogan M, Greenspan J, Challacombe SJ. Oral lesions in infection with human immunodeficiency virus. Bull World Health Organ 2005;83(9):700-6. [ Links ]

    8. Landerberger B, Egger M, Opravil M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort study. Lancet 1999 Mar;353(9156):863-8. [ Links ]

    9. Powderly WG, Saag MS, Chapman S, et al. Predictors of optimal virological response to potent antiretroviral therapy. AIDS 1999 Oct;13 (14):1873-80 [ Links ]

    10. Moreno S, Arrizabalaga J, Gatell JM, Clotet B, Aguirrebengoa K, Antela A, et al. Recommendations on antiretroviral treatment. The AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology. Med Clin1998 Jan;110(3) 109-16. [ Links ]

    11. Jané-Salas E, Chimenos-Küstner E, López-López J, Roselló-Llabrés X, Ocaña-Rivera I. Efecto de los tratamientos antirretrovirales en las manifestaciones orales de los pacientes VIH+. Av. Odontoestomatol 2006; 22(6):315-26. [ Links ]

    12. Aquirre JM, Echebarria MA, Ocina E, Ribacoba L, Montejo M. Reduction of HIV-associated oral lesions after highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999 Aug 88(2):114-5. [ Links ]

    13. Tappuni AR y Fleming GJ. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 Dec;92(6):623-8. [ Links ]

    14. Rodríguez M. Manifestaciones orales asociadas con la infección por VIH-SIDA. Rev Cubana Estomatol 2005 Ene 42;(1). [ Links ]

    15. Ranganathan K, Umadevi M, Saraswathi TR, Kumarasamy N, Solomon S, Johnson N. Oral lesions and conditions associated with human immunodeficiency virus infection in 1000 South Indian patients. Ann Acad Med Singapore 2004 Jul;33(4):37-42. [ Links ]

    16. Lourenço AG, Figueiredo LT. Oral lesions in HIV infected individuals from Ribeirão Preto, Brazil. Med Oral Patol Oral Cir Bucal. 2008 May 1;13 (5):281-6. [ Links ]

    17. Bravo IM, Correnti M, Escalona L, Perrone M, Brito A, Tovar V, Rivera H. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population. Med Oral Patol Oral Cir Bucal. 2006 Jan 1;11(1): 33-9. [ Links ]

    18. Miziara ID, Weber R. Oral lesions as predictors of highly active antiretroviral therapy failure in Brazilian HIV-infected children. J Oral Pathol Med 2008 Feb;37(2):99-106. [ Links ]

    19. Ceballos-Salobreña A, Gaitaín-Cepeda L, Ceballos-García L, et al. Prevalence of oral lesions by Candida sp: Their varieties and serotypes in a population of patients with AIDS under a highly active antiretroviral therapy. Rev Iberoam Micol 1998 Jul;15:141-5. [ Links ]

    20. Hamza OJ, Matee MI, Simon EN, Kikwilu E, Moshi MJ, Mugusi F, Mikx FH, Verweij PE, van der Ven AJ. Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health 2006 Aug 18;6:12. [ Links ]

    21. Nicolatou-Galitis O, Velegraki A, Paikos S, Economopoulou P, Stefaniotis T, Papanikolaou IS, Kordossis T. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study. Oral Dis 2004 May;10 (3):145-50. [ Links ]

    22. Kolokotronis A, Kioses V, Antoniades D, Mandraveli K, Doutsos I, Papanayotou P. Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1994 Jul;78(1): 41-6. [ Links ]

    23. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996 May 24;272(5265):1167-70. [ Links ]

    24. Baqui A, Meiller T, Jabra-Rizk M, Zhang M, Kelley J, Falkler W. Association of HIV viral load with oral diseases. Oral Dis 1999 Oct;5(4):294-8. [ Links ]

    25. Da Silva CA, Dourado I, Dahia SR, Harzheim E, Rutherford GW. Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil. J Public Health Dent 2008 Summer;68(3):178-81. [ Links ]

    26. Blignaut E, Patton LL, Nittayananta W, Ramirez-Amador V, Ranganathan K, Chattopadhyay A. (A3) HIV Phenotypes, oral lesions, and management of HIV-related disease. Adv Dent Res 2006 Apr 1;19(1):122-9. [ Links ]